Abstract
The proteins expressed by a genome have been termed the proteome.1,2 Comparative proteome analysis of brain tissue offers a novel means to identify biologically significant gene products that underlie psychopathology. In this study we collected post mortem hippocampal tissue from the brains of seven schizophrenic, seven Alzheimer's disease (AD) and seven control individuals. Hippocampal proteomes were visualised by two-dimensional gel electrophoresis of homogenised tissue. A mean of 549 (s.d. 35) proteins were successfully matched between each disease group and the control group. In comparison with the control hippocampal proteome, eight proteins in the schizophrenic hippocampal proteome were found to be decreased and eight increased in concentration, whereas, in the AD hippocampal proteome, 35 proteins were decreased and 73 were increased in concentration (P < 0.05). one protein, which was decreased in concentration in both diseases, was characterised as diazepam binding inhibitor (dbi) by n-terminal sequence analysis. dbi can regulate the action of the gabaA receptor.3,4 Protein changes involved 6% of the assessed AD hippocampal proteome, whereas, in schizophrenia protein changes involved less than 1% of the assessed hippocampal proteome. We conclude that schizophrenia has a subtle neuropathological presentation and comparative proteome analysis is a viable means by which to investigate diseases of the brain at the molecular level.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Edgar, P., Schonberger, S., Dean, B. et al. A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals. Mol Psychiatry 4, 173–178 (1999). https://doi.org/10.1038/sj.mp.4000463
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000463
Keywords
This article is cited by
-
Mass spectrometry for the detection of potential psychiatric biomarkers
Journal of Molecular Psychiatry (2013)
-
Neuroproteomics: understanding the molecular organization and complexity of the brain
Nature Reviews Neuroscience (2009)
-
The role of proteomics in dementia and Alzheimer’s disease
Acta Neuropathologica (2009)
-
Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity
Journal of Neural Transmission (2006)
-
Pathogenesis of peroxisomal deficiency disorders (Zellweger syndrome) may be mediated by misregulation of the GABAergic system viathe diazepam binding inhibitor
BMC Pediatrics (2004)